Clinical News and Research

RSS

Revealing How Interferon-Gamma Stops Tumor Cell Growth

At the UCLA Jonsson Comprehensive Cancer Center, scientists have uncovered a novel function for a protein known as extracellular signal-regulated kinase (ERK) within a pathway activated by interferon-gamma, capable of inducing cellular self-destruction.

11 Oct 2023

New Tool to Improve Genetic Analysis and Research

Rutgers researchers have created an analytical technique for detecting and removing stray DNA and RNA that contaminate single-celled organism genetic analysis.

11 Oct 2023

BioLizard Launches New AI-Empowered “BioVerse” Platform to Facilitate Data-Driven R&D for Global Life Sciences Community

BioLizard, the bioinformatics, data analytics and data management service and consulting company heading digital transformation in the life sciences industry, today announced the launch of its new BioVerse platform.

11 Oct 2023

Researchers Develop Bio-Inspired Drug to Boost Efficacy of Cancer Immunotherapy

A new, bio-inspired drug restores the effectiveness of immune cells in fighting cancer, a team led by researchers at The University of Texas at Austin has found.

10 Oct 2023

Rutgers Researchers Develop New Tool to Improve Accuracy of Single-Cell Genetic Analyses

Rutgers researchers have developed an analytical tool for spotting and omitting stray DNA and RNA that contaminate genetic analyses of single-celled organisms.

10 Oct 2023

Targeting Microbiota 2023: A Ground-Breaking Experience in Microbiome Research

Targeting Microbiota 2023 will be a ground-breaking experience that will introduce you to the latest advancements in the microbiota field.

6 Oct 2023

The Astute White Blood Cell Defense

Neutrophils, the most prevalent kind of white blood cell, are able to block Candida albicans toxin, according to study from Umeå University. EMBO Reports has published the findings.

6 Oct 2023

New Approach to Treating Age-Related Diseases by Targeting Aging Cells

A research team, led by Professor Ja Hyoung Ryu from the Department of Chemistry at UNIST, in collaboration with Professor Hyewon Chung from Konkuk University, has achieved a significant breakthrough in the treatment of age-related diseases.

5 Oct 2023

Scientists Gain Insights into Biophysical Properties of Neurons with New Workflow

Biophysically detailed neuronal models provide a unique window into the workings of individual neurons.

5 Oct 2023

Wildling Mice With High Microbial Exposure can Develop Allergies

The notion that some level of microbial exposure might reduce our risk of developing allergies has arisen over the last few decades and has been termed the hygiene hypothesis.

3 Oct 2023

Biosynth Extends Its Offering to Multi-Kilogram GMP Peptide Synthesis Through the Acquisition of Pepceuticals

Biosynth, a supplier of critical materials to the life science industry, is pleased to announce the acquisition of Pepceuticals, a UK producer of synthetic peptides with multi-kilogram GMP facilities and fill-finish capabilities designed to support customers from clinical trials to commercial supply.

26 Sep 2023

How Scientists are Using iPSCs to Develop New Therapies

In 1998, scientists reported being able to derive cells from human embryos that could develop into almost any cell in the body. In 2007, the field took a huge leap when scientists discovered they could reprogram human adult skin cells to act like these embryonic stem cells.

20 Sep 2023

New Device Mimics Biology to Detect Disease

In living organisms, cells have a very high capacity to process and communicate information by moving molecules or ions through tiny channels that span the cell membrane. UC Santa Cruz Professor of Electrical and Computer Engineering Marco Rolandi's lab and collaborators at MIT have created a device that mimics this biological concept in order to detect disease.

19 Sep 2023

Broken String Biosciences Closes $15M Series A Funding Round

Broken String Biosciences today announced that it has closed a $15 million Series A investment round, co-led by Illumina Ventures and Mérieux Equity Partners, with contributions from HERAN Partners, and existing investors Tencent and Dieter von Holtzbrinck Ventures.

19 Sep 2023

NICER Gene Editing Technique Reduces Unintended Mutations

The gene editing technique CRISPR/Cas9 has allowed researchers to make precise and impactful changes to an organism's DNA to fix mutations that cause genetic disease.

15 Sep 2023

Key Proteins in Human Breast Milk Crucial for Baby’s Healthy Gut

The abundance of two species of bacteria known to be good for human health and used as probiotics, Clostridium butyricum and Parabacteroides distasonis, has been linked to high concentrations of key proteins in human breast milk, particularly osteopontin and κ-casein.

13 Sep 2023

Scientists Uncover New Genetic Insights into Staphylococcus Aureus

New genetic insights into Staphylococcus aureus have been discovered by Australian researchers, showing what makes the bacteria so hazardous when it enters the bloodstream.

13 Sep 2023

African BioGenome Project Bridges the Gap in Biodiversity Genomics and Bioinformatics

Since its inception in 2021, the African BioGenome Project (AfricaBP), has made significant gains towards its ambitious goal of sequencing 100,000 endemic African species within the next 10 years.

13 Sep 2023

Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer

llumina today announced that its Board of Directors has appointed Jacob Thaysen, Ph.D., as Chief Executive Officer, effective September 25, 2023.

5 Sep 2023

Largest Genetic Study Discovers Specific DNA Changes That Increase Risk of Epilepsy

The largest genetic study of its kind, coordinated by the International League Against Epilepsy, including scientists from FutureNeuro at RCSI University of Medicine and Health Sciences, has discovered specific changes in our DNA that increase the risk of developing epilepsy.

5 Sep 2023

Clinical News and Research

Revealing How Interferon-Gamma Stops Tumor Cell Growth

New Tool to Improve Genetic Analysis and Research

BioLizard Launches New AI-Empowered “BioVerse” Platform to Facilitate Data-Driven R&D for Global Life Sciences Community

Researchers Develop Bio-Inspired Drug to Boost Efficacy of Cancer Immunotherapy

Rutgers Researchers Develop New Tool to Improve Accuracy of Single-Cell Genetic Analyses

Targeting Microbiota 2023: A Ground-Breaking Experience in Microbiome Research

The Astute White Blood Cell Defense

New Approach to Treating Age-Related Diseases by Targeting Aging Cells

Scientists Gain Insights into Biophysical Properties of Neurons with New Workflow

Wildling Mice With High Microbial Exposure can Develop Allergies

Biosynth Extends Its Offering to Multi-Kilogram GMP Peptide Synthesis Through the Acquisition of Pepceuticals

How Scientists are Using iPSCs to Develop New Therapies

New Device Mimics Biology to Detect Disease

Broken String Biosciences Closes $15M Series A Funding Round

NICER Gene Editing Technique Reduces Unintended Mutations

Key Proteins in Human Breast Milk Crucial for Baby’s Healthy Gut

Scientists Uncover New Genetic Insights into Staphylococcus Aureus

African BioGenome Project Bridges the Gap in Biodiversity Genomics and Bioinformatics

Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer

Largest Genetic Study Discovers Specific DNA Changes That Increase Risk of Epilepsy

The Exclusome, A New Mammalian "Containter"

Breaking Down the Onso System: PacBio's Genomic Advancement

The Last Piece of Our Genome: Sequencing the Y Chromosome

Latest in Genomics